GAMMA Investing LLC grew its position in shares of DuPont de Nemours, Inc. (NYSE:DD - Free Report) by 51.4% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 12,381 shares of the basic materials company's stock after buying an additional 4,201 shares during the period. GAMMA Investing LLC's holdings in DuPont de Nemours were worth $849,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also made changes to their positions in DD. Ritholtz Wealth Management boosted its holdings in DuPont de Nemours by 48.8% in the first quarter. Ritholtz Wealth Management now owns 4,462 shares of the basic materials company's stock worth $333,000 after purchasing an additional 1,464 shares during the period. Sequoia Financial Advisors LLC lifted its position in shares of DuPont de Nemours by 334.4% in the 1st quarter. Sequoia Financial Advisors LLC now owns 256,053 shares of the basic materials company's stock worth $19,122,000 after buying an additional 197,115 shares during the last quarter. Cambridge Investment Research Advisors Inc. boosted its holdings in shares of DuPont de Nemours by 6.6% in the 1st quarter. Cambridge Investment Research Advisors Inc. now owns 80,385 shares of the basic materials company's stock valued at $6,003,000 after buying an additional 4,995 shares during the period. Oppenheimer & Co. Inc. boosted its holdings in shares of DuPont de Nemours by 11.8% in the 1st quarter. Oppenheimer & Co. Inc. now owns 54,489 shares of the basic materials company's stock valued at $4,069,000 after buying an additional 5,751 shares during the period. Finally, Summit Trail Advisors LLC grew its position in shares of DuPont de Nemours by 37.4% during the 1st quarter. Summit Trail Advisors LLC now owns 23,923 shares of the basic materials company's stock valued at $1,787,000 after buying an additional 6,509 shares during the last quarter. 73.96% of the stock is owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
A number of equities analysts have commented on the company. BMO Capital Markets decreased their target price on DuPont de Nemours from $107.00 to $104.00 and set an "outperform" rating for the company in a research note on Friday, September 19th. UBS Group boosted their price objective on DuPont de Nemours from $87.00 to $89.00 and gave the company a "buy" rating in a research report on Monday, July 21st. Mizuho upped their price objective on DuPont de Nemours from $80.00 to $85.00 and gave the stock an "outperform" rating in a research note on Tuesday, July 15th. KeyCorp raised their target price on DuPont de Nemours from $92.00 to $93.00 and gave the company an "overweight" rating in a research note on Monday. Finally, Wells Fargo & Company boosted their price target on shares of DuPont de Nemours from $81.00 to $90.00 and gave the company an "overweight" rating in a report on Monday, July 14th. Nine analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to data from MarketBeat.com, DuPont de Nemours has a consensus rating of "Moderate Buy" and a consensus price target of $88.33.
Check Out Our Latest Analysis on DuPont de Nemours
Insider Activity
In other news, SVP Steven P. Larrabee sold 43,208 shares of the business's stock in a transaction on Monday, September 15th. The stock was sold at an average price of $77.17, for a total value of $3,334,361.36. Following the sale, the senior vice president owned 38,585 shares of the company's stock, valued at approximately $2,977,604.45. The trade was a 52.83% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In the last 90 days, insiders sold 74,208 shares of company stock worth $5,714,861. 0.61% of the stock is currently owned by company insiders.
DuPont de Nemours Stock Down 0.9%
DuPont de Nemours stock opened at $77.52 on Wednesday. DuPont de Nemours, Inc. has a 52 week low of $53.77 and a 52 week high of $90.06. The stock has a market cap of $32.46 billion, a price-to-earnings ratio of -164.94, a PEG ratio of 2.26 and a beta of 1.07. The company's 50-day moving average price is $75.18 and its two-hundred day moving average price is $70.92. The company has a current ratio of 1.41, a quick ratio of 0.94 and a debt-to-equity ratio of 0.23.
DuPont de Nemours (NYSE:DD - Get Free Report) last issued its quarterly earnings results on Tuesday, August 5th. The basic materials company reported $1.12 earnings per share for the quarter, topping analysts' consensus estimates of $1.06 by $0.06. The company had revenue of $3.26 billion during the quarter, compared to analyst estimates of $3.23 billion. DuPont de Nemours had a negative net margin of 1.54% and a positive return on equity of 7.85%. The business's revenue for the quarter was up 2.7% compared to the same quarter last year. During the same period in the prior year, the business posted $0.97 EPS. DuPont de Nemours has set its FY 2025 guidance at 4.400-4.400 EPS. Q3 2025 guidance at 1.150-1.150 EPS. On average, analysts expect that DuPont de Nemours, Inc. will post 4.38 EPS for the current fiscal year.
About DuPont de Nemours
(
Free Report)
DuPont de Nemours, Inc provides technology-based materials and solutions in the United States, Canada, the Asia Pacific, Latin America, Europe, the Middle East, and Africa. It operates through Electronics & Industrial, Water & Protection, and Corporate & Other segments. The Electronics & Industrial segment supplies materials and solutions for the fabrication of semiconductors and integrated circuits.
Featured Articles
Want to see what other hedge funds are holding DD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DuPont de Nemours, Inc. (NYSE:DD - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider DuPont de Nemours, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DuPont de Nemours wasn't on the list.
While DuPont de Nemours currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for October 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.